Chair Chosen for New Neurology Department

Dr. Lyden helped lead trial of clot-busting drug

Patrick D. Lyden, M.D., FAAN, a highly respected neurologist who has conducted extensive research into cerebrovascular disease and potential treatments for stroke, has been named chair of the newly designated Department of Neurology at Cedars-Sinai Medical Center.

The announcement was made by Shlomo Melmed, M.D., Senior Vice President for Academic Affairs and Dean of the Medical Faculty, and Mark R. Gavens, Senior Vice President for Clinical Care Services and Chief Operating Officer, who said Dr. Lyden's expertise will further strengthen Cedars-Sinai's standing as one of the most progressive centers for neurological care and research in California.

Dr. Lyden, who also will hold the Carmen and Louis Warschaw Chair in Neurology, has conducted extensive research into cerebrovascular disease and potential treatments for stroke. He helped lead the pivotal trial of the clot-busting drug tissue plasminogen activator (tPA) and shared a prestigious "Cine" award with the National Institute of Neurological Disorders and Stroke for producing and directing a training video that is now used around the world.

Prior to his appointment, which became effective July 1, Dr. Lyden served the Department of Neurosciences at the University of California, San Diego, as Professor and Vice Chairman for Clinical Neurology, and served the UCSD Medical Center as Clinical Chief of Neurology and Director of the Stroke Center.

Dr. Lyden's research has consistently been funded by the National Institutes of Health. He has published more than 200 journal articles and abstracts and has edited a textbook on stroke intervention. He lectures frequently at national and international conferences and is on the editorial boards of the International Journal of Stroke, The Stroke Interventionalist, and the Journal of Stroke and Cerebrovascular Disease.

Cedars-Sinai's Stroke Program and neurology services have increased in scope and prominence in recent years with recruitment of highly respected neurologists and neurosurgeons, as well as investments in innovative interventional tools and therapies. The Stroke Program recently received its second consecutive Gold Award from the American Stroke Association - recognition of sustained performance achievement - and received certification as a Primary Stroke Center by The Joint Commission.